Penn cancer study funded by Sean Parker releases results
The Parker Institute for Cancer Immunotherapy, a cancer research consortium funded by Silicon Valley tech billionaire Sean Parker that includes Penn’s Perelman School of Medicine, published its first successful collaborative study on Monday.